XenoSTART

XenoSTART is a global nonclinical oncology contract research organisation focused on the development and utilisation of patient-derived xenograft models. Founded in 2007, XenoSTART was created in close collaboration with The START Center, an international cancer treatment and research organisation. This partnership provides the unique ability to generate clinically-relevant XenoSTART patient-derived xenograft (XPDX) models.
Our XPDX models are clinically annotated and include patient treatment history and outcome and are characterised through genomic profiling, histologic analysis, and in vivo drug sensitivity to relevant standards of care